Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4295892)

Published in Cancer Epidemiol Biomarkers Prev on October 09, 2014

Authors

Mireia Obón-Santacana1, Petra H M Peeters2, Heinz Freisling3, Laure Dossus4, Françoise Clavel-Chapelon4, Laura Baglietto5, Helena Schock6, Renée T Fortner6, Heiner Boeing7, Anne Tjønneland8, Anja Olsen8, Kim Overvad9, Virginia Menéndez10, Maria-José Sanchez11, Nerea Larrañaga12, José María Huerta Castaño13, Aurelio Barricarte14, Kay-Tee Khaw15, Nick Wareham16, Ruth C Travis17, Melissa A Merritt18, Antonia Trichopoulou19, Dimitrios Trichopoulos20, Philippos Orfanos21, Giovanna Masala22, Sabina Sieri23, Rosario Tumino24, Paolo Vineis25, Amalia Mattiello26, H B Bueno-de-Mesquita27, N Charlotte Onland-Moret28, Elisabeth Wirfält29, Tanja Stocks30, Annika Idahl31, Eva Lundin32, Guri Skeie33, Inger T Gram33, Elisabete Weiderpass34, Elio Riboli18, Eric J Duell35

Author Affiliations

1: Unit of Nutrition, Environment, and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
2: Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands.
3: Dietary Exposure Assessment Group, International Agency for Research on Cancer, Lyon, France.
4: Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones, and Women's Health team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.
5: Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Australia.
6: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
7: Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany.
8: Danish Cancer Society Research Center, Copenhagen, Denmark.
9: Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
10: Public Health Directorate, Asturias, Spain.
11: Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria de Granada (Granada.ibs), Granada, Spain. Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain.
12: Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain. Public Health Division of Gipuzkoa-BIODONOSTIA, Basque Regional Health Department, Spain.
13: Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain. Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain.
14: Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain. Navarre Public Health Institute, Pamplona, Spain.
15: University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
16: MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
17: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
18: Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
19: Hellenic Health Foundation, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.
20: Hellenic Health Foundation, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
21: Hellenic Health Foundation, Athens, Greece. Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Goudi, Athens, Greece.
22: Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.
23: Epidemiology and Prevention Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milano, Italy.
24: Cancer Registry and Histopathology Unit, "Civic - M.P. Arezzo" Hospital, ASP Ragusa, Italy.
25: Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. Human Genetics Foundation, Torino, Italy.
26: Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
27: Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands. Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
28: Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands.
29: Department of Clinical Sciences, Nutrition Epidemiology, Lund University, Malmö, Sweden.
30: Department of Clinical Sciences, Nutrition Epidemiology, Lund University, Malmö, Sweden. Umeå University, Department of Perioperative and Surgical Sciences, Sweden.
31: Department of Clinical Sciences, Obstetrics and Gynecology and Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden.
32: Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
33: Department of Community Medicine, Faculty of Health Sciences, UiT The Artic University of Norway, Tromsø, Norway.
34: Department of Community Medicine, Faculty of Health Sciences, UiT The Artic University of Norway, Tromsø, Norway. Cancer Registry of Norway, Oslo, Norway. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Department of Genetic Epidemiology, Folkhälsan Research Center, Helsinki, Finland.
35: Unit of Nutrition, Environment, and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain. eduell@iconcologia.net.

Articles cited by this

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77

Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2003) 5.18

Ovarian cancer. Annu Rev Pathol (2009) 4.92

Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem (2002) 2.76

Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol (2005) 1.69

A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.32

A lifetime oncogenicity study in rats with acrylamide. Fundam Appl Toxicol (1995) 1.31

Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2011) 1.27

Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study. Int J Cancer (2011) 1.22

Dietary acrylamide and human cancer. Int J Cancer (2006) 1.05

IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals. Lyon, 15-22 February 1994. IARC Monogr Eval Carcinog Risks Hum (1994) 1.05

The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit Rev Toxicol (2010) 1.05

Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide. Cancer Causes Control (2008) 1.04

A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev (2010) 1.00

Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Cancer Epidemiol Biomarkers Prev (2009) 0.97

Associations between estimated acrylamide intakes, and hemoglobin AA adducts in a sample from the Malmö Diet and Cancer cohort. Eur J Clin Nutr (2007) 0.95

Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. Toxicol Sci (2007) 0.91

The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure. Cancer Causes Control (2007) 0.91

Dietary acrylamide exposure and hemoglobin adducts--National Health and Nutrition Examination Survey (2003-04). Food Chem Toxicol (2010) 0.91

Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans. Cancer Epidemiol Biomarkers Prev (2007) 0.90

Dietary acrylamide intake of adults in the European Prospective Investigation into Cancer and Nutrition differs greatly according to geographical region. Eur J Nutr (2012) 0.88

In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans. Cancer Epidemiol Biomarkers Prev (2009) 0.85

Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2013) 0.82

Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Ann Oncol (2013) 0.80

Challenges in estimating the validity of dietary acrylamide measurements. Eur J Nutr (2012) 0.79

Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Br J Cancer (2014) 0.79

Articles by these authors

Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol (2014) 3.00

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet (2014) 2.39

Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer (2015) 1.82

A genome-wide pleiotropy scan for prostate cancer risk. Eur Urol (2014) 1.48

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One (2016) 1.40

Exercise training improves cardiopulmonary and endothelial function in women with breast cancer: findings from the Diana-5 dietary intervention study. Intern Emerg Med (2015) 1.39

Progress in Medicine: Experts Take Stock. PLoS Med (2015) 1.16

Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study. Eur J Epidemiol (2016) 1.07

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol (2017) 1.00

Long-term exposure to elemental constituents of particulate matter and cardiovascular mortality in 19 European cohorts: results from the ESCAPE and TRANSPHORM projects. Environ Int (2014) 0.97

The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res (2014) 0.96

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet (2016) 0.93

Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet (2014) 0.93

Dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal women: a prospective cohort study. PLoS One (2014) 0.93

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort. Clin Cancer Res (2016) 0.92

Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiol (2012) 0.92

Genome-Wide Association Study of Prostate Cancer-Specific Survival. Cancer Epidemiol Biomarkers Prev (2015) 0.91

Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study. BMJ Open (2014) 0.91

Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev (2014) 0.91

Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort. Int J Cancer (2015) 0.90

General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2015) 0.89

Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition. Int J Cancer (2015) 0.89

Residential exposure to traffic noise and health-related quality of life--a population-based study. PLoS One (2015) 0.89

Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev (2015) 0.89

Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and Nurses' Health Study (NHS) and NHSII. Cancer Epidemiol Biomarkers Prev (2015) 0.89

Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr (2015) 0.88

A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer. PLoS One (2014) 0.88

Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis (2014) 0.87

Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer (2015) 0.87

Life-course socioeconomic status and DNA methylation of genes regulating inflammation. Int J Epidemiol (2015) 0.86

Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort. Am J Clin Nutr (2015) 0.86

Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort. Cancer Epidemiol Biomarkers Prev (2015) 0.85

Nutrient patterns and their food sources in an International Study Setting: report from the EPIC study. PLoS One (2014) 0.84

Plasma elaidic acid level as biomarker of industrial trans fatty acids and risk of weight change: report from the EPIC study. PLoS One (2015) 0.84

Mortality in vegetarians and comparable nonvegetarians in the United Kingdom. Am J Clin Nutr (2015) 0.83

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. Cancer Res (2016) 0.82

What characterises women who eat potatoes? A cross-sectional study among 74,208 women in the Norwegian Women and Cancer cohort. Food Nutr Res (2015) 0.80

Dietary Intake Estimates and Urinary Cadmium Levels in Danish Postmenopausal Women. PLoS One (2015) 0.80

Prolactin determinants in healthy women: A large cross-sectional study within the EPIC cohort. Cancer Epidemiol Biomarkers Prev (2014) 0.79

Early pregnancy sex steroids and maternal breast cancer: a nested case-control study. Cancer Res (2014) 0.79

The association of substituting carbohydrates with total fat and different types of fatty acids with mortality and weight change among diabetes patients. Clin Nutr (2015) 0.79

A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS Med (2016) 0.79

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget (2016) 0.78

Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study. Int J Cancer (2015) 0.78

Interaction between genetic predisposition to adiposity and dietary protein in relation to subsequent change in body weight and waist circumference. PLoS One (2014) 0.78

Body iron status and gastric cancer risk in the EURGAST study. Int J Cancer (2015) 0.78

Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr (2016) 0.78

Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort. Int J Cancer (2015) 0.78

Prediagnostic intake of dairy products and dietary calcium and colorectal cancer survival--results from the EPIC cohort study. Cancer Epidemiol Biomarkers Prev (2014) 0.78

Plasma alkylresorcinol concentrations, biomarkers of whole-grain wheat and rye intake, in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Br J Nutr (2014) 0.78